Navigation Links
Vapotherm® Announces FDA Clearance for Precision Flow® Heliox System

STEVENSVILLE, Md., Oct. 27, 2011 /PRNewswire-USNewswire/ -- Vapotherm announced today receiving FDA clearance for Precision Flow® Heliox, a high flow humidification system designed specifically for use with blended helium oxygen gas mixtures (Heliox).  The product is part of Vapotherm's High Flow Specialty Gas Program for optimal conditioning of breathing gases. Heliox is used in a variety of respiratory applications such as upper airway obstruction, asthma, croup and COPD. "We are pleased to receive clearance for the new Precision Flow® Heliox system, the first high flow device developed specifically for use with this specialty gas," said Bill Niland, Chief Business Development Officer at Vapotherm.  "The device provides clinicians with a rapid, easy to use approach to administer heliox via nasal cannula, without the risks of more invasive methods like mechanical ventilation and pressure based therapies."

Vapotherm's High Flow Specialty Gas Program was created to expand High Flow Therapy (HFT®) beyond air and oxygen to other medical and specialty gases.  The Company's flagship platform device, the Precision Flow, was developed with a modular design concept to allow for several specialty applications in neonatal, pediatric and adult patient populations. In all applications, the device optimizes the delivery of gases via precise blending, flow control, humidification and temperature management.  As with all Vapotherm HFT® products, the overall goal is non-invasive respiratory support via simple nasal cannula in a device that is easy for clinicians to operate but comprehensive in terms of safety and performance features.

Vapotherm, Inc. is a privately held manufacturer of respiratory care devices for hospitals and home care use based in Stevensville, Maryland. The Company is dedicated to the development of innovative, noninvasive technologies for respiratory therapy, especially for the treatment of chronic lung and acute breathing disorders. For more information, visit

Contact: Kevin Thibodeau, Executive Vice President of Sales and Marketing


SOURCE Vapotherm, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vapotherm® Receives FDA 510(k) Clearance for Flowrest® Homecare Device
2. China Kanghui Holdings Announces Participation in Upcoming Investor Conferences
3. Ground Zero Pharmaceuticals, Inc. (GZP) Announces Expansion of Oncology Programs for Its Clients
4. Idenix to Host Conference Call Discussing Third Quarter and Nine Month 2011 Financial Results and Announces Presentations at the American Association for the Study of Liver Diseases Meeting (AASLD)
5. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2011 Financial Results
6. CMC Biologics Announces Agreement With Daiichi Sankyo Company to Develop and Manufacture Antibodies
7. Global Pharm Announces the Closing of US$15 Million Redeemable Convertible Bonds Financing
8. Intellect Neurosciences Announces Its New CONJUMAB-A Platform Technology for Novel Treatments of Alzheimers Disease and Other Proteinopathies
9. Perrigo Company Announces Quarterly Dividend
10. MiMedx Group Announces Third Quarter 2011 Results
11. Anthera Announces Last Patient Enrolled in PEARL-SC Study
Post Your Comments:
(Date:11/26/2015)... 26, 2015 Research and Markets ( ) ... Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders ... report to their offering. Boston ... Boston scientific and others. --> ... Biotronik, Boston scientific and others. ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 ... the addition of the "2016 Future Horizons ... Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, ... offering. --> ... comprehensive analysis of the Japanese therapeutic drug monitoring ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Testing Market: Supplier Shares, Competitive ... offering.  --> ) ... "2016 Future Horizons and Growth Strategies ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors ... treat it. Surviving Mesothelioma has just posted the findings on the website. Click ... analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed by ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced a ... customers 10% off of their purchase of lice treatment product. In addition, customers will ... to a company spokesperson. “Finding lice is a sure way to ruin the holidays, ...
(Date:11/27/2015)... ANGELES, CA (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating ... of 30 (see Table 1-1 ). More than 3.7 billion people under the ... virus type 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection . ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television ... an interesting show that delves into an array of issues that are presently affecting ... benefit from open dialogue, this show is changing the subjects consumers focus on, one ...
(Date:11/27/2015)... ... 2015 , ... CBD College is proud to announce that on ... accreditation to its Diagnostic Medical Sonography program. CBD College is honored to join this ... colleges and universities in the state of California make the cut. CBD College is ...
Breaking Medicine News(10 mins):